3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Melanoma
11
Leukemia, Myeloid, Acute
5
Uveal Melanoma
4
Prostatic Neoplasms
4
Myelodysplastic Syndromes
4
Uterine Cervical Neoplasms
3
Sarcoma
3
Multiple Myeloma
3
Lymphoma, Non-Hodgkin
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Hodgkin Disease
3
Gastrointestinal Stromal Tumors
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Neuroblastoma
2
Neoplasm Metastasis
2
Lymphoma, Follicular
2
Lymphoma, B-Cell
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Hematologic Neoplasms
2
Gliosarcoma
2
Fallopian Tube Neoplasms
2
Colorectal Neoplasms
2
Brain Neoplasms
2
Testicular Neoplasms
1
Teratoma, Testicular
1
Teratoma
1
Squamous Cell Carcinoma of Head and Neck
1
Interventions
enzalutamide
6
radium Ra 223 dichloride
5
Docetaxel
2
Abiraterone Acetate
2
zimberelimab
1
xentuzumab
1
sacituzumab govitecan
1
quemliclustat
1
pembrolizumab
1
atezolizumab
1
apalutamide
1
Standard of Care
1
Radium-223
1
Prednisone
1
Nivolumab
1
Ipilimumab
1
Drug Therapy
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Prostatic Neoplasms, Castration-Resistant
×
CTLA-4 Antigen
×
Clear all
NCT04717154
2026-01-06
INSPIRE
Radboud University Medical Center
Phase 2
Completed
69 enrolled